TrialBMC cancer2025

The efficacy of premedication with 10 mg versus 20 mg of intravenous dexamethasone for prevention of paclitaxel hypersensitivity reaction in low-risk gynecologic cancer patients: a non-inferiority, randomized controlled mono-institutional trial.

Nutthakarn Sa-Ngiamphorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.